JMISMDL
A MarginJMI Syringes & Medical Devices Ltd. · Pharmaceuticals & Chemicals
No lists yet
Create on Stocks pageKey Statistics
JMI Syringes & Medical Devices Ltd.
Pharmaceuticals & Chemicals sector stock listed on DSE since 2013.
Trading Info
Capital Structure
External Links
Auditor's report, period ended Jun 2025: Emphasis of matter. Read the filing
Credit rating AA long term, ST-1 short term, stable outlook. Alpha, announced 23 Dec 2025.
Valuation
Dividend History
Cash dividend declared, as a percentage of face value, with any bonus shares beside it. A dash means the year was not reported.
EPS History
Share Distribution
The Board of Directors has recommended 10% Final Cash Dividend (i.e. BDT 1.00 per share) for the year ended June 30, 2026. Date of AGM: December 23, 2...
The Board of Directors has recommended 10% Final Cash Dividend (i.e. BDT 1.00 per share) for the year ended June 30, 2026. Date of AGM: December 23, 2026 at 11.30 A.M., Venue/Mode of AGM: 27th AGM will be held virtually by using digital platform at https://jmismdl.bdvirtualagm.com. Record Date: November 23, 2026. The Company has also reported EPS of Tk. (2.00), NAV per share of Tk. 84.23 and NOCFPS of Tk. 0.16 for the year ended June 30, 2026 as against Tk. 1.49, Tk. 87.23 and Tk. 3.57 respectively for the year ended June 30, 2025.
There will be no price limit on the trading of the shares of the Company today (27.10.2026) following its corporate declaration.
There will be no price limit on the trading of the shares of the Company today (27.10.2026) following its corporate declaration.
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.
The company has informed that the Board of Directors in its Meeting held on September 22, 2026 has resolved to change the Share Office of the Company...
The company has informed that the Board of Directors in its Meeting held on September 22, 2026 has resolved to change the Share Office of the Company as follows: Old Address: Plot# 29/C & 29/D (2nd Floor), Tejgaon Industrial Area, Dhaka-1208, Bangladesh. New Address: House#430/1/A (4th Floor), Tejgaon Industrial Area, Dhaka-1208, Bangladesh. Registered Office address remains unchanged. Corporate and Correspondence Office address remains unchanged. The change of Share Office will be effective from 1st October, 2026.
(Q3 Un-audited): EPS was Tk. (2.39) for January-March 2026 as against Tk. (0.02) for January-March 2025; EPS was Tk. (2.89) for July 2025-March 2026 a...
(Q3 Un-audited): EPS was Tk. (2.39) for January-March 2026 as against Tk. (0.02) for January-March 2025; EPS was Tk. (2.89) for July 2025-March 2026 as against Tk. 1.68 for July 2024-March 2025. NOCFPS was Tk. 2.07 for July 2025-March 2026 as against Tk. 2.67 for July 2024-March 2025. NAV per share was Tk. 83.34 as on March 31, 2026 and Tk. 87.23 as on June 30, 2025. (cont.1) Significant Deviation: EPS: A) During the reported period Net profit after Tax and Earning per Share (EPS) are decreased in comparison with previous period due to decrease of sales and increases of all type of expenses. B) The Company has been adjusted as loss of BDT 7,54,27,421/- against flood damaged inventory for the previous period which has leading decreased EPS additionally in this period. (cont.2) NAVPS: The net asset value per share decreased significantly due to the net loss after tax in the business during the period compared to previous period. NOCFPS: Net operating cash flow has been decreased slightly due to net losses, increased material purchases and increased closing inventory in the current period compared to previous period.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 2:35 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
(Q2 Un-audited): EPS was Tk. (0.01) for October-December 2025 as against Tk. 0.98 for October-December 2024; EPS was Tk. (0.51) for July-December 2025...
(Q2 Un-audited): EPS was Tk. (0.01) for October-December 2025 as against Tk. 0.98 for October-December 2024; EPS was Tk. (0.51) for July-December 2025 as against Tk. 1.71 for July-December 2024. NOCFPS was Tk. (0.63) for July-December 2025 as against Tk. 2.93 for July-December 2024. NAV per share was Tk. 85.72 as on December 31, 2025 and Tk. 87.23 as on June 30, 2025. Reasons for deviations: During the reported period Net profit after Tax and EPS are decreased in comparison with previous period due to decrease of sales and increases of all type of expenses. NOCFPS has been negative significantly due to net losses, increased material purchases and increased closing inventory in the current period compared to previous period. The net asset value per share decreased slightly due to the net loss after tax in the business during the period compared to previous period.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2026 at 2:35 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
Alpha Credit Rating PLC. (Alpha Rating) has assigned surveillance rating of the Company as "AA" in the long term and "ST-1" in the short term along wi...
Alpha Credit Rating PLC. (Alpha Rating) has assigned surveillance rating of the Company as "AA" in the long term and "ST-1" in the short term along with Stable outlook based on audited financial statements as on June 30, 2025 and relevant qualitative information till December 21, 2025.
Momentum
Price ৳122.50-2.68 · signal -2.5 · hist -0.17
Price vs averages
Go Deeper on This Stock
RSI, MACD, Bollinger Bands, and 12+ indicators — calculated and ready for every listed stock.
Compare Plans
Order Book
Orders waiting to buy and sell on DSE right now. Best bid and ask are free; the full ladder is Pro.
The order book could not be loaded.
Best bid
Spread
Best ask
See the Whole Order Book
Ten price levels on each side, live through the session: how much is queued to buy and to sell, and where.
Compare Plans
Big negotiated deals made outside the normal market. Heavy block activity often signals institutional interest.
Block Trades
See What Big Investors Traded Today
Block transactions reveal institutional buying and selling that don't show up in regular price data.
Compare Plans